|
HAUS5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.022110E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.688020E-02 |
| Normal-vs-Stage2 |
5.194100E-02 |
| Normal-vs-Stage3 |
2.807900E-02 |
| Normal-vs-Stage4 |
6.237800E-01 |
| Stage1-vs-Stage2 |
9.782600E-01 |
| Stage1-vs-Stage3 |
1.779190E-01 |
| Stage1-vs-Stage4 |
3.078400E-01 |
| Stage2-vs-Stage3 |
1.951960E-01 |
| Stage2-vs-Stage4 |
3.355400E-01 |
| Stage3-vs-Stage4 |
8.098100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.388700E-04 |
| Normal-vs-AfricanAmerican |
4.393900E-02 |
| Normal-vs-Asian |
1.854170E-01 |
| Caucasian-vs-AfricanAmerican |
1.396990E-01 |
| Caucasian-vs-Asian |
9.124000E-01 |
| AfricanAmerican-vs-Asian |
6.955200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.615900E-03 |
| Normal-vs-Female |
2.363700E-03 |
| Male-vs-Female |
4.037800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.069700E-02 |
| Normal-vs-Extreme_Weight |
8.296300E-03 |
| Normal-vs-Obese |
7.835500E-04 |
| Normal-vs-Extreme_Obese |
7.990400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.471400E-01 |
| Normal_Weight-vs-Obese |
6.647500E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.283400E-01 |
| Extreme_Weight-vs-Obese |
6.871200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.707600E-02 |
| Obese-vs-Extreme_Obese |
8.213600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.718080E-02 |
| Normal-vs-Age(41-60Yrs) |
1.620390E-03 |
| Normal-vs-Age(61-80Yrs) |
4.921200E-03 |
| Normal-vs-Age(81-100Yrs) |
2.708000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.241000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.611200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.516400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.119400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.561600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.951010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.013300E-04 |
| Normal-VS-Type2 PRCC |
1.266570E-01 |
| Normal-VS-KIRP CIMP |
5.190400E-01 |
| Normal-VS-Unclassified PRCC |
4.350100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.806000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.015600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.023010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.455800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.861700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.298400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.442100E-02 |
| Normal-vs-N1 |
1.173530E-02 |
| Normal-vs-N2 |
9.577800E-01 |
| N0-vs-N1 |
5.402400E-01 |
| N0-vs-N2 |
6.005800E-01 |
| N1-vs-N2 |
2.671400E-01 |
|
|
